Structures by: Trzewik B.
Total: 9
1,1'-[4-hydroxy-2-(hydroxymethyl)-1,3-dioxolane-2,4-diyl]di(butan-1-one)
C12H20O6
New J. Chem. (2016) 40, 11 9291
a=5.46953(4)Å b=25.01189(17)Å c=10.72878(9)Å
α=90° β=113.0587(7)° γ=90°
1,1'-[4-hydroxy-2-(hydroxymethyl)-1,3-dioxolane-2,4-diyl]di(butan-1-one)
C12H20O6
New J. Chem. (2016) 40, 11 9291
a=5.4695Å b=25.0119Å c=10.7288Å
α=90° β=113.059° γ=90°
(E)-5-(4-Methylpyridin-2-yl)-2-phenyl-3-(phenylimino)-1,2,5- oxadiazinan-4-one
C21H18N4O2
New Journal of Chemistry (2010) 34, 10 2220
a=10.3512(3)Å b=10.5145(3)Å c=10.8469(4)Å
α=116.607(2)° β=115.147(2)° γ=94.549(2)°
(Z)-2-(phenylamino)-2-(phenylimino)-N-(pyridin-2-yl)ethanamide
C19H16N4O
New Journal of Chemistry (2010) 34, 10 2220
a=26.1851(8)Å b=9.1055(3)Å c=13.7491(6)Å
α=90.00° β=98.881(1)° γ=90.00°
(Z)-N-(4-methylpyridin-2-yl)-2-(phenylamino)-2- (phenylimino)ethanamide
C20H18N4O
New Journal of Chemistry (2010) 34, 10 2220
a=13.5564(3)Å b=10.1570(3)Å c=13.3227(4)Å
α=90.000° β=109.473(1)° γ=90.000°
N-Pyridin-2-yl-5H-dibenzo(d,f)(1,3)diazepine-6-carboxamide
C19H14N4O
New Journal of Chemistry (2010) 34, 10 2220
a=10.3641(2)Å b=11.7961(3)Å c=14.4961(4)Å
α=89.766(1)° β=69.834(1)° γ=70.166(1)°
<i>N</i>-(4-Methylpyridin-2-yl)-5<i>H</i>-dibenzo[d,f][1,3]diazepine-6- carboxamide toluene hemisolvate
C20H16N4O,0.5(C7H8)
Acta Crystallographica Section E (2007) 63, 10 o4115-o4115
a=8.9323(2)Å b=9.6863(2)Å c=12.1478(3)Å
α=77.0500(10)° β=87.5290(10)° γ=70.1910(10)°
(2Z)-2-Anilino-2-[oxido(phenyl)iminio]-N-(2-pyridyl)acetamide methanol 0.425-solvate
C19H16N4O2,0.425CH4O
Acta Crystallographica Section E (2008) 64, 3 o599-o600
a=18.7604(3)Å b=9.4701(2)Å c=21.2839(5)Å
α=90.00° β=104.3750(10)° γ=90.00°
<i>N</i>-(5-Nitropyridin-2-yl)-5<i>H</i>- dibenzo[<i>d</i>,<i>f</i>][1,3]diazepine-6-carboxamide
C19H13N5O3
Acta Crystallographica Section E (2011) 67, 6 o1507
a=12.9702(2)Å b=9.21040(10)Å c=13.4145(2)Å
α=90.000° β=100.6920(10)° γ=90.000°